Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Clin Microbiol ; 54(7): 1907-1911, 2016 07.
Artigo em Inglês | MEDLINE | ID: mdl-27122377

RESUMO

Two screening methods to detect staphylococcal colonization in humans were compared. Direct plating to CHROMagar (BD Diagnostics) was compared to a broth preenrichment followed by plating to Baird-Parker agar. The broth-enrichment method was comparable to CHROMagar for methicillin-resistant Staphylococcus aureas (MRSA) detection, but the enrichment method was optimum for recovery of coagulase-positive Staphylococcus spp.


Assuntos
Técnicas Bacteriológicas/métodos , Portador Sadio/diagnóstico , Programas de Rastreamento/métodos , Resistência a Meticilina , Infecções Estafilocócicas/diagnóstico , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/isolamento & purificação , Portador Sadio/microbiologia , Meios de Cultura/química , Humanos , Infecções Estafilocócicas/microbiologia
2.
Infect Control Hosp Epidemiol ; 36(4): 387-93, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25782892

RESUMO

OBJECTIVE: The major mechanism of fluoroquinolone (FQ) resistance in Pseudomonas aeruginosa (PSA) is modification of target proteins in DNA gyrase and topoisomerase IV, most commonly the gyrA and parC subunits. The objective of this study was to determine risk factors for PSA with and without gyrA or parC mutations. DESIGN: Case-case-control study SETTING: Two adult academic acute-care hospitals PATIENTS: Case 1 study participants had a PSA isolate on hospital day 3 or later with any gyrA or parC mutation; case 2 study participants had a PSA isolate on hospital day 3 or later without these mutations. Controls were a random sample of all inpatients with a stay of 3 days or more. METHODS: Each case group was compared to the control group in separate multivariate models on the basis of demographics and inpatient antibiotic exposure, and risk factors were qualitatively compared. RESULTS: Of 298 PSA isolates, 172 (57.7%) had at least 1 mutation. Exposure to vancomycin and other agents with extended Gram-positive activity was a risk factor for both cases (case 1 odds ratio [OR], 1.09; 95% confidence interval [CI], 1.04-1.13; OR, 1.14; 95% CI, 1.03-1.26; case 2 OR, 1.09; 95% CI, 1.03-1.14; OR, 1.13; 95% CI, 1.01-1.25, respectively). CONCLUSIONS: Exposure to agents with extended Gram-positive activity is a risk factor for isolation of PSA overall but not for gyrA/parC mutations. FQ exposure is not associated with isolation of PSA with mutations.


Assuntos
DNA Girase/genética , DNA Topoisomerase IV/genética , Mutação/genética , Pseudomonas aeruginosa/genética , Antibacterianos/efeitos adversos , Antibacterianos/uso terapêutico , Estudos de Casos e Controles , Infecção Hospitalar/genética , Infecção Hospitalar/microbiologia , Farmacorresistência Bacteriana/genética , Feminino , Humanos , Levofloxacino/uso terapêutico , Masculino , Pessoa de Meia-Idade , Infecções por Pseudomonas/genética , Infecções por Pseudomonas/microbiologia , Fatores de Risco , Vancomicina/efeitos adversos , Vancomicina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA